메뉴 건너뛰기




Volumn 23, Issue 2, 2009, Pages 488-489

Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

EID: 60149083507     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.55     Document Type: Letter
Times cited : (40)

References (8)
  • 2
  • 6
    • 28344440277 scopus 로고    scopus 로고
    • Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy
    • Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005; 112: 2088-2094.
    • (2005) Ophthalmology , vol.112 , pp. 2088-2094
    • Ober, M.D.1    Yannuzzi, L.A.2    Do, D.V.3    Spaide, R.F.4    Bressler, N.M.5    Jampol, L.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.